Iqvia Holdings (IQV) Free Cash Flow (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Free Cash Flow came in at $360.0 million in Q2 2026, up 23.29% year-over-year from $292.0 million in Q2 2025, and down 26.68% quarter-over-quarter from $491.0 million in Q1 2026.
Analysis
Iqvia Holdings (IQV) Free Cash Flow (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Free Cash Flow across 15 years of filings, most recently posting $360.0 million for Q2 2026.
- In Q2 2026, Free Cash Flow rose 23.29% year-over-year to $360.0 million; the TTM figure through Jun 2026 stood at $2.2 billion (up 8.66% YoY), while the FY2025 annual figure was $2.1 billion, down 2.98% from the prior year.
- Free Cash Flow came in at $360.0 million for Q2 2026 at Iqvia Holdings, down from $491.0 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $772.0 million in Q3 2025 to a low of $168.0 million in Q2 2022.
- Average Free Cash Flow over 5 years is $450.1 million, with a median of $431.5 million recorded in 2023.
- Year-over-year, Free Cash Flow slumped 57.36% in 2022 and surged 83.88% in 2024.
- Over 5 years, Free Cash Flow stood at $389.0 million in 2022, then soared by 46.02% to $568.0 million in 2023, then grew by 26.94% to $721.0 million in 2024, then fell by 22.19% to $561.0 million in 2025, then slumped by 35.83% to $360.0 million in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were $360.0 million in Q2 2026, $491.0 million in Q1 2026, and $561.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 360.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 138.10 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 323.69 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 148.62 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 19.90 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -46.89 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -617,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -2.84 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -3.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 360.00 Mn |
| Mar 31, 2026 | 491.00 Mn |
| Dec 31, 2025 | 561.00 Mn |
| Sep 30, 2025 | 772.00 Mn |
| Jun 30, 2025 | 292.00 Mn |
| Mar 31, 2025 | 426.00 Mn |
| Dec 31, 2024 | 721.00 Mn |
| Sep 30, 2024 | 571.00 Mn |
| Jun 30, 2024 | 445.00 Mn |
| Mar 31, 2024 | 377.00 Mn |
| Dec 31, 2023 | 568.00 Mn |
| Sep 30, 2023 | 437.00 Mn |
| Jun 30, 2023 | 242.00 Mn |
| Mar 31, 2023 | 253.00 Mn |
| Dec 31, 2022 | 389.00 Mn |
| Sep 30, 2022 | 698.00 Mn |
| Jun 30, 2022 | 168.00 Mn |
| Mar 31, 2022 | 331.00 Mn |
| Dec 31, 2021 | 508.00 Mn |
| Sep 30, 2021 | 682.00 Mn |